Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces cardiac events compared to placebo in patients at risk of renal injury undergoing coronary angiography for acute coronary syndrome, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
Risk Adjusted Net Present Value: What is the current valuation of Fusion Pharmaceuticals’s FPI-1434
The revenue for FPI-1434 is expected to reach an annual total of $65 mn by 2039 in the US based off GlobalData’s Expiry Model. The
July 31, 2023